Acesso livre
Acesso livre

Outras notícias

Causas do câncer hepático estão mudando ao redor do mundo: algumas ganham força, outras perdem.

19 Jun, 2022 | 13:17h

Comunicado de imprensa: Causes of Liver Cancer are Changing Around the World: Some Up, Some Down – UC San Diego Health

Estudo original: Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer – Cell Metabolism (link para o resumo – $ para o texto completo)


Inibidor de SGLT2 reduz o risco de hiperpotassemia em pacientes com insuficiência cardíaca.

19 Jun, 2022 | 13:15h

Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled – European Heart Journal

Editorial: Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure

Conteúdo relacionado: Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial – European Heart Journal

 

Comentário no Twitter

Sob a licença de https://creativecommons.org/licenses/by-nc/4.0/


Análise de especialista | Tratamento da pericardite na gestação.

19 Jun, 2022 | 13:13h

Pericarditis Management in Pregnancy – American College of Cardiology


Estudo | Maioria dos homens que morrem em decorrência de suicídio não tinham nenhuma condição de saúde mental conhecida.

19 Jun, 2022 | 13:12h

Comentário: Most Males Who Die by Suicide Have No Known Mental Health Condition – Psychiatric News Alert

Estudo original: Suicide Among Males Across the Lifespan: An Analysis of Differences by Known Mental Health Status – American Journal of Preventive Medicine


Estudo de coorte | Desfechos de longo prazo com o uso precoce de antipsicóticos injetáveis de ação prolongada na esquizofrenia.

19 Jun, 2022 | 13:10h

Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia – The Journal of Clinical Psychiatry (link to abstract – $ for full-text)

Comentário: Patients With Schizophrenia Switched Early to LAIs Show Markedly Better Long-Term Outcomes – Psychiatric News Alert

Conteúdos relacionados:

Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis – The Lancet (link para o resumo – $ para o texto completo)

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link para o resumo – $ para o texto completo)

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link para o resumo – $ para o texto completo)

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial – JAMA Psychiatry


Imunoterapia direcionada ao hospedeiro para infecções virais e bacterianas: passado, presente e futuro.

19 Jun, 2022 | 13:07h

Host-directed immunotherapy of viral and bacterial infections: past, present and future – Nature Reviews Immunology (se o acesso a este link for pago, tente este no PMC)

 

Comentário no Twitter

 


Relatos de caso | Terapia com talidomida em 18 pacientes com malformação arteriovenosa grave.

19 Jun, 2022 | 13:06h

Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations – Nature Cardiovascular Research (link para o resumo – $ para o texto completo)

Comentário: Thalidomide is an effective treatment for abnormal blood vessel formations – European Society of Human Genetics


Revisão sistemática | Oxicodona para dor relacionada a câncer.

19 Jun, 2022 | 13:05h

Oxycodone for cancer‐related pain – Cochrane Library

Resumo: Oxycodone for cancer-related pain in adults – Cochrane Library


DNA circulante de tumor e recorrência tardia em câncer de mama de alto risco, positivo para receptor de hormônio e negativo para receptor do fator de crescimento epidérmico humano 2.

19 Jun, 2022 | 13:04h

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer – Journal of Clinical Oncology

Editorial: Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor–Positive Early Breast Cancer?

Comentário: Tumor DNA Assay Portends Metastatic Breast Cancer Recurrence Months in Advance — First evidence for patients in late adjuvant setting, years after initial diagnosis – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

 


Seguimento de 2 anos de estudo de braço único | Ciltacabtageno Autoleucel, uma terapia de células T do receptor de antígeno quimérico anticélula B de maturação, para mieloma múltiplo recorrente/refratário.

19 Jun, 2022 | 13:02h

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up – Journal of Clinical Oncology

Estudo original: Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study – The Lancet (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.